Improving Access to Care for Veterans With Memory Loss
Recruiting now · Not applicable
Conditions studied: Alzheimer Disease
In brief
This study evaluates a care delivery protocol to improve access to care for Veterans with Alzheimer's Disease and Related Disorders (ADRD). A randomized controlled trial will enroll Veterans with mild cognitive impairment or early dementia at VA Pittsburgh. The ADRD care delivery protocol integrates telehealth, advanced diagnostics, and streamlined workflows to expedite screening for eligibility for amyloid targeting therapies.
Key facts
- Study ID
- NCT07117162
- Run by
- VA Pittsburgh Healthcare System
- People needed
- 30
- Starts
- 2025-10-29
- Expected to finish
- 2027-06-01
- Last updated by the study team
- 2026-07-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of mild cognitive impairment or mild dementia due to suspected or confirmed AD with a 5 minute telephone MoCA score >7
- Meets VA MUE inclusion/exclusion criteria for mAb therapy for AD
- Enrolled in VA care
- Lives in a home setting (i.e., not in an institutional setting such as a nursing home, Community Living Center, or hospital)
- Has a working telephone
- 18 years and older
- Able to communicate in English
- Willing to give informed consent.
You may not qualify if…
- None
Where it is running
- VA Pittsburgh Healthcare System — Pittsburgh, Pennsylvania, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.